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Background: Electroconvulsive therapy (ECT) is an effective treatment for patients with
severe depression. Knowledge on factors predicting therapeutic response may help to
identify patients who will benefit most from the intervention. Based on the neuroplasticity
hypothesis, volumes of the amygdala and hippocampus are possible candidates for predict-
ing treatment outcome. Therefore, this prospective cohort study examines the predictive
value of amygdala and hippocampal volumes for the effectiveness of ECT.
Methods: Prior to ECT, 53 severely unipolar depressed patients [mean age 57±14 years;
40% (n=21) male] received structural magnetic resonance imaging (MRI) at 1.5T. Nor-
malized amygdala and hippocampal volumes were calculated based on automatic seg-
mentation by FreeSurfer (FS). Regression analyses were used to test if the normalized
volumes could predict the response to a course of ECT based on the Montgomery–Åsberg
Depression Rating Scale (MADRS) scores.
Results:A larger amygdala volume independently and significantly predicted a lower post-
ECT MADRS score (β=−0.347, P = 0.013).The left amygdala volume had greater predictive
value for treatment outcome relative to the right amygdala volume. Hippocampal volume
had no independent predictive value.
Conclusion: A larger pre-treatment amygdala volume predicted more effective ECT, inde-
pendent of other known predictors. Almost all patients continued their medication during
the study, which might have influenced the course of treatment in ways that were not
taken into account.
Keywords: electroconvulsive therapy, response, amygdala, predictive value, structural MRI
INTRODUCTION
Electroconvulsive therapy (ECT) is an effective treatment for
severely depressed patients (1, 2). ECT is a safe treatment option,
however, it is regarded as invasive and some cognitive adverse
effects are known (3). Although ECT is widely used, factors pre-
dicting ECT outcome are largely unknown. Knowledge on such
factors might help to identify patients most likely to benefit from
the intervention, and allow patients and clinicians to make better-
informed decisions about initiating ECT. Several clinical and treat-
ment characteristics were associated with increased response rates
to ECT, including the presence of psychotic symptoms (4, 5), pre-
vious response to ECT (6), higher administered electrical stimulus
intensity (7), bilateral electrode positioning (8), and higher age (9).
Structural neuroimaging could potentially be used to deter-
mine brain characteristics that predict ECT response, but until
now structural MRI characteristics were not well established
and showed contradictory results. For example, larger right
hippocampal volumes predicted a poorer outcome after a course
of ECT (10), whereas another study using visual rating scales to
score severity of atrophy, showed that atrophy in the medial tem-
poral lobe (MTL; a part of the brain including hippocampus and
amygdala) seemed to be negatively correlated with the response to
ECT (11).
The structural volumes of specific brain areas are partly deter-
mined by regional neuroplasticity. According to the neuroplastic-
ity hypothesis, knowledge on regional plasticity of specific brain
areas gives further insight into the pathophysiology of depression
and its treatment. Among other factors, regional neuroplastic-
ity was associated with the level of brain-derived neurotrophic
factor (BDNF; i.e., a factor involved in the regulation of neu-
ronal growth) (12). Contradicting results show that, within the
MTL, both increased and decreased regional brain volumes as
well as BDNF levels were associated with severe depression and its
treatment by ECT (13, 14).
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FIGURE 1 | Flow chart of the patient selection process.
Firstly, bidirectional alterations in plasticity of the amygdala, a
brain region that bears an important function in emotional mem-
ory and fear conditioning (13), were suggested to be related to
depression. Also, patients suffering from depression showed both
larger and smaller amygdala volumes relative to healthy controls
[for a review, see Ref. (15)]. Secondly, depression was associated
with relatively small volumes of the hippocampus (16). More-
over, a study using animal models of depression showed that
BDNF knock-down in specific sites of the hippocampus resulted
in depression-like behavior (17). The hippocampus is related to
the declarative memory system and seems to mediate the more
cognitive aspects of depression (e.g., feelings of worthlessness and
guilt) (18).
Emphasizing the involvement of plasticity in the treatment of
depression, studies on ECT and electroconvulsive shock (ECS; i.e.,
an animal model of ECT) showed that repeated ECT/ECS partially
reverses the relatively high and low BDNF levels found in the amyg-
dala and hippocampus, respectively, of depressed patients (19–
24). Also, a longitudinal pilot study showed an increase of both
amygdala and hippocampal volume due to an ECT course (25).
Recapitulating, according to the neuroplasticity hypothesis of
depression, the hippocampus, and the amygdala seemed to be
important structures in depression and the treatment with ECT.
This study investigates whether individual differences in pre-
treatment volumes of the amygdala and hippocampus predict the
level of depression after a course of ECT.
MATERIALS AND METHODS
PATIENTS
Only severely unipolar depressed patients classified according to
the Diagnostic and Statistical Manual of Mental Disorders, 4th
edition, Text Revision (DSM-IV-TR), indicated for ECT at the
Rijnstate Hospital (Arnhem, the Netherlands), were selected for
this study. Patients were excluded if aged <18 years, if they suf-
fered from bipolar disorder, if there were contraindications for
MRI of the brain, and if they dropped out of treatment during the
ECT course (Figure 1).
The Medical Ethical committee of the hospital approved the
research protocol of this study (NL24697.091.09). Characteris-
tics of the patients are described in more detail elsewhere (26).
After receiving full information about the study, written informed
consent was obtained from all participants.
INSTRUMENTS
Psychometric instruments
Information on age, sex, psychiatric diagnosis, and previous ECT
treatments were derived from the medical records. The severity of
depression was determined with the MADRS by a trained research
nurse. The MADRS consists of questions in 10 subcategories (27),
rated 0–6, resulting in a score ranging from 0 to 60 (highest level
of severity). Remission was defined as a post-ECT MADRS score
of ≤10 points (28). Clinical raters were blind to the MRI results.
MRI and volumetric analysis
Imaging was performed within 1 week before the first ECT ses-
sion on a 1.5 T MRI scanner (Philips Medical Instruments,
Best, the Netherlands), using an eight-channel SENSE head coil.
The scanning protocol included a high resolution T1-weighted
(T1W) turbo field echo MRI (sequence parameters: repetition
time= 7.6 ms; echo time= 3.5 ms; flip angle= 15°; 145 sagittal
slices; voxel size= 1.1 mm isotropic). Prior to analysis, all raw
MRI data were visually checked for the presence of (motion)
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artifacts. Regional volumes were established using the FS auto-
matic subcortical segmentation tool, in which each voxel in the
normalized brain volume is assigned one of about 40 labels, includ-
ing hippocampus and amygdala1. Briefly, the processing stream
comprises removal of the skull and dura, automated Talaraich
transformation, defining the gray–white matter boundary, inten-
sity normalization, and segmentation of subcortical gray matter.
We manually corrected the cases where dura was included in
the gray matter. The FS application enables automatic labeling
of subcortical structures using a probabilistic algorithm. Initially,
each image is a rigid body registered to a probabilistic atlas based
on manually labeled image. Thereafter, the image is morphed to
the atlas by a non-linear transform and a Bayesian segmentation
procedure is employed. Each voxel in the MRI volume is automat-
ically assigned to a neuro-anatomical label based on probabilistic
information estimated from a manually labeled training set. The
labeling procedure is not biased by anatomical variability. The
segmentation procedure is based on three types of probabilities
to disambiguate labels: first, the likelihood that a given structure
occurs at a specific atlas location. Second, the likelihood of the
image intensity given the tissue class. Third, the probability that a
voxel belongs to a given tissue class based on likelihood of the spa-
tial configuration of labels2. For each patient, the total volumes of
the amygdala and the hippocampus were normalized by dividing
each established volume by the total intracranial volume.
Treatment course and procedure
Electroconvulsive therapy was administered using a constant-
current (0.9 A), brief-pulse [0.25 ms in right unilateral ECT (RUL)
and 0.5 ms in bifrontotemporal (BL) ECT] device (maximum out-
put 1008 mC; Thymatron IV; Somatics Incorporation, Lake Bluff,
IL, USA), after induction of anesthesia intravenously with etomi-
date (0.3 mg/kg body mass), muscle paralysis with succinylcholine
(0.5–1 mg/kg body mass) intravenously, and with appropriate
oxygenation (100% oxygen, positive pressure) until the resump-
tion of spontaneous respiration. Electrode placement was started
RUL, except in patients at high risk for suicidality and/or acute
somatic complications of the depression, or if previous BL ECT
had successfully been administered. Dosage was set at 6-times ini-
tial seizure threshold (IST) in RUL ECT and at 2.5-times IST for
BL treatment. Patients were treated twice weekly. RUL electrode
placement could be changed into BL electrode placement during
the ECT course if the patient did not show (enough) improve-
ment after six RUL sessions, based on the clinical decision of
experienced psychiatrists. One week before starting ECT, baseline
MADRS scores were determined. The course of ECT treatment was
terminated when mood had not further improved in the last two
ECT sessions, based on the clinical decision of the psychiatrists.
Within 1 week after the last ECT session, the post-ECT MADRS
score was established.
STATISTICAL ANALYSIS
Data are presented as means± SD or numbers or percentages
when appropriate. The statistical assumptions for the regression
1http://surfer.nmr.mgh.harvard.edu/
2http://surfer.nmr.mgh.harvard.edu/fswiki
analyses were tested in advance. For the assumption of linearity,
residuals versus predicted values plot was created and interpreted.
The Durbin–Watson and the Shapiro–Wilk test were used to check
for violations of independence and normality, respectively.
Regression analyses were used to test if the normalized volumes
of hippocampus and amygdala predicted the effectiveness of ECT.
Primarily, the post-ECT MADRS score was the dependent variable
in regression analyses of covariance. The independent variables
were the normalized volumes of the amygdala and hippocampus,
adjusted for age, sex, baseline MADRS score, presence of psychotic
symptoms, and previous ECT treatment. These last two variables
were added because of their known predictive value for ECT effec-
tiveness (26). To assess whether post-ECT MADRS scores could
also be predicted for out-of-sample cases,we used cross-validation.
We computed the correlation between leave-one-out predicted
scores and the observed scores, and tested for a positive asso-
ciation using permutation testing with 1000 randomizations in
Matlab (R2014a).
For further confirmation, binary logistic regressions were used
to test if the normalized volumes were predictive of the remit-
ted group (post-ECT MADRS score≤ 10) relative to the non-
remitters. In this analysis, remission or not served as the dependent
variable, and the normalized volumes as independent variables,
adjusted for age, sex, baseline MADRS score, presence of psychotic
depression and previous ECT treatment. To examine whether the
effect was lateralized, analyses that produced significant effects
were repeated separately with the left and right area volumes
as independent variables. Additionally, since both BL and RUL
electrode placements were applied, the eventual electrode place-
ment (i.e., the electrode placement that was used to complete the
treatment) was included as a possible mediator in an analysis of
covariance (ANCOVA) in which the same variables were included
as in the regression analysis. In all tests, P < 0.05 denoted statisti-
cal significance; SPSS for Windows (version 20) was used for the
analyses.
RESULTS
PATIENT CHARACTERISTICS
The study included 53 severely unipolar depressed patients,
with a mean age of 57± 14 (SD) years, of which 21 (39.6%)
were male. Out of 53 patients, 33 (62.3%) patients used ben-
zodiazepines, 35 (66%) used anti-depressants, 34 (64.2%) used
anti-psychotics, and 2 (3.8%) used anti-epileptics. Most patients
(94.3%) suffered from longstanding, recurrent depressive disor-
der, and 16 (30.2%) patients were previously treated with ECT.
The mean baseline MADRS score was 36.0± 8.1 (SD) points
and psychotic symptoms were present in 12 (22.6%) patients
(Table 1). The mean number of treatment sessions in a com-
pleted ECT course was 18.2± 7.4 (SD). At the initial session, 42
patients (79.2%) were treated with RUL ECT. Twenty (37.7%)
of these patients switched from RUL to BL treatment, leaving
22 (41.5%) patients who were eventually treated with RUL treat-
ment. After ECT, the mean MADRS score decreased significantly
[t (52)= 13.07,P < 0.001] to a mean score of 13.5± 10 (SD). After
the ECT course, 26 (49.1%) patients achieved complete remis-
sion. The patients who achieved remission did not significantly
differ from the non-remitting patients in age (P = 0.213), sex
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Table 1 | Patient and anatomical magnetic resonance imaging (MRI)
descriptives at baseline of severely unipolar depressed patients
(n=53) treated with electroconvulsive therapy (ECT).
Mean±SD or n (%)
Patient characteristics
Age (in years) 57.1±14.3
Male gender 21 (39.6)
MADRS score at baseline 36.0±8.1
Presence of psychotic features 16 (30.2)
Previously treated with ECT 12 (22.6)
Total number of sessions 18.2±7.4
Concomitant medication
Benzodiazepines 33 (62.3)
Anti-depressants 35 (66.0)
Anti-psychotics 34 (64.2)
Anti-epileptics 2 (3.8)
MRI volumes of regions of interest (in mm3)
Bilateral amygdala 4741±624
Bilateral hippocampus 6711±972
SD, standard deviation; MADRS, Montgomery–Åsberg Depression Rating Scale.
(P = 0.958), total number of ECT sessions (P = 0.151), or use of
concomitant medication [i.e., benzodiazepines (P = 0.227), anti-
depressants (P = 0.920), anti-psychotics (P = 0.344), and anti-
epileptics (P = 0.172)]. Also, comparison of the patients that were
eventually treated with RUL and BL electrode placement revealed
no differences in age (P = 0.748), sex (P = 0.474), total number of
ECT sessions (P = 0.734), or use of concomitant medication [i.e.,
benzodiazepines (P = 0.464), anti-depressants (P = 0.786), anti-
psychotics (P = 0.227), and anti-epileptics (P = 0.233)].
ECT OUTCOME RELATED TO THE VOLUME OF AMYGDALA AND
HIPPOCAMPUS
Adjusted for age, sex, baseline MADRS score, presence of psy-
chotic symptoms, previous ECT course(s), and eventual electrode
placement, the linear regression analyses of covariance revealed
that the normalized bilateral amygdala volume independently
predicted 12.9% of the variance in the post-ECT MADRS score
within this specific model. Specifically, a larger pre-ECT nor-
malized amygdala volume predicted a lower post-ECT MADRS
score (Figure 2; β=−0.347, P = 0.013). Moreover, as expected,
the presence of psychotic depression (β=−0.406, P = 0.014) and
previous ECT treatment(s) (β=−0.344, P = 0.021) showed sig-
nificant predictive values for lower post-ECT MADRS scores.
In this model, the normalized bilateral hippocampus volume
did not predict the post-ECT MADRS score (β=−0.065,
P = 0.691).
To assess whether post-ECT MADRS scores could also be pre-
dicted for new cases on the basis of bilateral amygdala volume
after correction for covariates, we calculated predicted post-ECT
MADRS scores using linear regression with leave-one-out cross-
validation. The correlation between predicted scores and observed
scores approached significance (r = 0.274, P = 0.068), suggesting
that ECT outcome can be predicted by a combination of amygdala
volume and clinical variables.
Adjusted for age, sex, baseline MADRS score, presence of psy-
chotic symptoms, previous ECT course(s), and eventual electrode
placement, the binary logistic analyses confirmed our results by
showing that a larger normalized amygdala volume also predicted
remission after ECT (P = 0.028).
Identical regression analyses of the normalized left and right
amygdala separately revealed a greater effect for the normalized left
amygdala (β=−0.346, P = 0.013) compared to the normalized
right amygdala (β=−0.245, P = 0.080).
DISCUSSION
This prospective cohort study in severely depressed patients
showed that a larger pre-treatment amygdala volume predicted
lower post-ECT depressive symptom score and remission after
ECT. More specific, a larger left amygdala predicted better outcome
of ECT. By contrast, the hippocampal volume had no predictive
value for treatment outcome.
A study in elderly patients showed that more MTL atrophy
correlated with less response to ECT (11). Because this study deter-
mined atrophy on a four-point rating scale by subjective rating of
a radiologist, no differentiation between amygdala and hippocam-
pal volume could be made. Our present study showed a correlation
between ECT response and pre-ECT amygdala volume and not the
hippocampus volume, rather than the MTL as a whole.
Remarkably, we could not replicate a correlation between
poorer treatment response and larger pre-ECT hippocampal
volume (10). Several factors might have affected this discrep-
ancy in results. For instance, this might be due to the fact
that Lekwauwa and colleagues did not adjust for any con-
founding factors. In our analyses, age (r =−0.463, P < 0.001),
sex (r =−0.270, P = 0.025), and presence of psychotic features
(r =−0.265, P = 0.028) all showed significant partial correlation
with the normalized hippocampal volume. Therefore, one of these
factors might have confounded the previously reported correlation
between hippocampal volume and ECT response (10).
To assess whether ECT outcome could also be predicted for
new cases, we predicted post-ECT depressive symptom scores for
individual patients on the basis of data from the rest of the group
using leave-one-out cross-validation. The result approached sig-
nificance and tentatively suggests that the outcome of ECT can
be predicted on the basis of a combination of amygdala vol-
ume and clinical variables. This result provides further support
to our recent report that ECT outcome can be predicted using
neuroimaging data (29). In that study, we analyzed functional
and structural MRI data on a voxel-by-voxel basis using machine
learning. However, whereas functional MRI data were predictive
of ECT outcome, structural MRI data were not. Several method-
ological differences may have contributed to the differences in
results between the current and previous study. First, we defined
the amygdala on an anatomical basis and analyzed its volume in
isolation in the present study, whereas we analyzed brain mor-
phology across the entire brain on a voxel-by-voxel basis in the
previous study. Second, the regression analysis accounted for the
influence of clinical variables such as psychosis or previous ECT,
whereas our machine learning analysis did not. Third, the required
effect size to detect significant effects is different, as we had an
a priori hypothesis for the amygdala in the current study, whereas
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FIGURE 2 | Scatter plot and regression line for the post-electroconvulsive therapy (ECT) established Montgomery–Åsberg Depression Rating Scale
(MADRS) scores against the normalized amygdala volume (amygdala volume/intracranial volume).
we explored effects across the entire brain in the previous study.
Regardless of these differences, both studies suggest that the out-
come of ECT can be predicted using neuroimaging data,and future
studies may investigate whether combining structural and func-
tional MRI data could provide even better predictions of ECT
outcome.
To explain the prediction of a better treatment response by a
larger pre-ECT amygdala volume, we will focus on the hypoth-
esized functional role of the amygdala in recovery from depres-
sion. A study in medication-naive depressed patients showed that
treatment response was dependent on the amygdala retaining its
plasticity during the course of illness (30). In our present study,
although patients suffered mostly from chronic, recurrent depres-
sions, retaining plasticity may still be important in achieving
remission after a course of ECT. Moreover, compared to pre-ECT,
post-ECT activity was shown to be increased in the mediotempo-
ral lobe (31–33), and more specifically in the amygdala (34). At
last, other studies showed relatively large mediotemporal lobe vol-
umes (35) and high intra-amygdalar functional amino acids (36)
specifically in patients that responded positively to ECT. Thus,
previous studies have shown that retaining plasticity during the
course of illness and large post-ECT volumes of the amygdala
correlated with a positive ECT response. We hypothesize that the
pre-ECT amygdala volume is related to these findings. That is, a
larger pre-ECT amygdala volume might reflect relatively higher
levels of retained intra-regional plasticity and it might also facil-
itate larger post-ECT amygdala volumes. Thus, a large pre-ECT
amygdala volume might predict positive ECT response because a
larger volume reflects greater capacity for the amygdala to fulfill
its functional role in the recovery of depression by ECT, suggested
by previous research (30, 35, 36). However, the data in the present
study was not suited to test this hypothesis, since no post-ECT
MRI data was collected.
The present study had some strengths and limitations that
should be mentioned. First, the prospective nature of the study
diminished the potential sources of bias and confounding factors
that were associated with the retrospective design. Furthermore,
compared with previous studies, the present sample size was rela-
tively large. On the other hand, almost all patients continued their
medication during the study, which might have influenced the
course of treatment in ways that were not taken into account. At
last, the number of treatment sessions per patient was high relative
to other studies [see, for example, Ref. (37)]. This is probably best
explained by the high degree of treatment resistance of the patients
who are treated with ECT in the Netherlands.
CONCLUSION
In conclusion, in this group of severely, mostly longstanding and
recurrent, unipolar depressed patients, a larger amygdala volume
predicted a more favorable ECT outcome. Further research, apply-
ing several MRI techniques, is needed to replicate these results and
extend the findings to other groups of patients and treatments.
Clinically, if replicated in other samples, pre-ECT amygdala vol-
ume might help clinicians and patients to better predict treatment
response and make better-informed decisions about initiating
ECT.
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